CHI3L1 and metabolic dysfunction-associated steatotic liver disease: Indeed, a complete phenotypic analysis of the type and characteristics of the inflammatory cells infiltrating the liver by immunohistochemistry will be of interest in a larger cohort of NASH and NAFLD patients in the context of increased Chi3L1 expression and a focus in future studies.